Study highlights glycolysis as a potential therapeutic target to combat Mycobacterium tuberculosis

It has been uncertain how Mycobacterium tuberculosis deflects the immune response in humans, though evidence has pointed to host immunometabolism -; the intrinsic link between metabolism in immune cells and their immune function.

bonyf Advances to Phase 2 in Development of Alginate-Organic Denture Fixative Cream – Biotech Investments

bonyf NV / Key word(s): Research Update/Product Launch bonyf Advances to Phase 2 in Development of Alginate-Organic Denture Fixative Cream 04-Apr-2024 / 18:17 CET/CEST bonyf

April 5, 2024

Intellia, Verve run clinical trials abroad amid FDA’s ‘cautious’ approach to gene editing

Intellia Therapeutics announced earlier this month that it would run a mid-stage trial of a CRISPR-based treatment for a rare genetic disease called hereditary angioedema

August 18, 2023

Navigating the Final CMS Medicaid Managed Care Rule

Gary Jessee, Senior Vice President of Sellers Dorsey On April 22, 2024, the Centers for Medicare & Medicaid Services (CMS) released the final rule, Medicaid

July 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.